Pathophysiological roles of atherosclerotic carotid plaque phenotypes and bioactive substances in patients undergoing carotid endarterectomy
Not Applicable
- Conditions
- 1. Atherosclerosis 2. Stroke 3. Carotid stenosis 4. Diabetes
- Registration Number
- JPRN-UMIN000019115
- Lead Sponsor
- ational Hospital Organization, Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects who have been determined to be unsuitable for the attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method inflammatory mediators IL-6,IL-10,TNFalfa,MCP-1 activation/inflammatory markers in plaque and peripheral blood monocytes MHC-II, CD86, Dectin-1, CD206, CD16, CD68
- Secondary Outcome Measures
Name Time Method body weight,BMI,waist circumference,blood pressure,HbA1c,FPG,TC,TG,LDL-C,HDL-C, UA,BUN,Cre